Delve Health and cerascreen® Announce a Partnership to Offer a "One-Stop Solution" Digital Healthcare App

MINNEAPOLIS, May 11, 2023 /PRNewswire/ -- Delve Health, a virtual health and technology firm, and cerascreen^®, an at-home health diagnostic testing company, are announcing an exciting partnership to expand access to digital healthcare solutions worldwide via smart and wearable devices (e.g., smart phones, tablets, wrist wearables, etc.).

Delve Health provides a fully-customizable mobile and web-based platform that enables cerascreen consumers the opportunity to monitor and track their health data—supporting and empowering people to take a more active role in their own healthcare journey. "Our solution was designed to increase awareness and access to personalized healthcare. We knew our platform needed to be user-friendly to ensure consumers would adopt and engage with it, but most importantly we knew that the platform needed to be device agnostic so consumers could use whatever device (e.g., Apple Watch, FitBit, Samsung Watch, Garmin Watch, etc.) or operating system (e.g., iOS, Android, etc.) they have already adopted into their daily lives. Taking a human-centric approach was imperative because increasing a person's engagement with the app leads to better results for their health," said Wessam Sonbol, the founder and CEO of Delve Health.

He also shared that "… as seasoned and innovative technology providers, we understand that consumers will be more engaged with the platform if they feel it is easy to use and they can easily see the benefits to their well-being. Delve Health is dedicated to supporting personalized and preventative healthcare companies, such as cerascreen, in order to ensure their success because when they "win" so do their health-conscious consumers; who are taking positive, knowledge-based steps to living healthier, happier lifestyles. This partnership was designed to provide the technical capabilities to support and guide people to meaningful next steps, once they have their lab results.

"We look forward to our partnership, as Delve Health's platform offers full-integration, regardless of which device or devices our customers prefer, and customization to each and every in-home test we offer. This enables us to increase healthcare access to consumers by providing testing kits they can complete in the comfort of their own homes, regardless of their geographical location or access to transportation and doctors," said Philip Groth, CEO of cerascreen. "Digital healthcare offers increased access to patients, wherever they live in the world, and it empowers them to take charge of their own health at a low-cost compared to traditional avenues of testing," he added.

While virtual and/or digital healthcare solutions were being designed and offered prior to 2020, its more widespread acceptance by the industry was no doubt accelerated by the COVID-19 pandemic. Regulatory bodies and providers around the world have consistently addressed the need for more cost-effective and equitable access to healthcare. Partnerships like Delve Health and cerascreen's will continue to remove social determinants of health (SDOH) factors, making healthcare and self-driven well-being more affordable and fairly accessible for all who want to participate.

Readers interested in obtaining additional information on how this partnership will benefit the public at-large by leveraging technology solutions and wearable devices to take charge of their own health and well-being can request it here.

Clinical research sites and sponsors interested in discussing our customized end-to-end solutions in order to effectively design and successfully conduct patient-centric decentralized clinical trials, please contact Delve Health at [email protected]. 

About Delve Health
Delve Health has been leading decentralized clinical trials (DCTs) with a multi-modal platform to provide a customizable solution that fits every trial. Our unified platform is fully-configurable, which allows sponsors to pick and choose the necessary components for each individual study. This could be a combination of digital recruitment; patient engagement; eConsent; TeleVisit; ePRO/eCOA; site data capture; sensors; and analytics.  Our global team of experts is committed to improving hybrid decentralized clinical studies with technology solutions that patients want to use and clinical researchers can trust. Delve Health is a privately held company, headquartered in Minneapolis, MN with remote offices in Florida and Washington, DC, as well as a European office in the United Kingdom.

For more information, visit: www.delvehealth.com

Follow our LinkedIn updates: www.linkedin.com/company/delve-health

About cerascreen^® 
We are cerascreen—a young health company based in Hamburg and Schwerin, Germany, and now serving more than a dozen European countries. We develop medical selftest kits to do at home and offer our consumer carefully selected nutritional supplements to balance their relevant biomarkers. We also provide coaching and courses on topics related to health, nutrition, and fitness. cerascreen stands for prevention and a healthy life. We help consumers to better understand their body, track the right biomarkers and use them to establish healthier habits in terms of exercise, nutrition and regeneration.

We do that, whether consumers want to alleviate discomfort, navigate through difficult phases of life, age healthily, change your lifestyle or improve your athletic or professional performance. 

For more information, visit: www.cerascreen.com
Follow our LinkedIn updates: www.linkedin.com/company/cerascreen

CONTACT:
+1.952.200.6228
[email protected]

SOURCE Delve Health